P r o g r a m

Invited Speakers
Speaker
Donghyun Lim

Donghyun Lim

Hanyang University, Korea

Session I-A Islet/Beta Cell Research
Speaker
Baicheng Kuang

Baicheng Kuang

Huazhong University of Science and Technology, China

Session I-A A β-Cell-Derived Metabolite Acts as A Signaling Molecule Specifically Targeting Adipocytes to Maintain Metabolic Homeostasis
Chair
Hao Yin

Hao Yin

Shanghai Changzheng Hospital, China

Session I-A Cadaveric and Stem-Cell-Derived Islet Transplantation in Shanghai
Chair
Shohta Kodama

Shohta Kodama

Fukuoka University, Japan

Session I-A History of Islet Transplantation in Japan
Speaker
Takayuki Anazawa

Takayuki Anazawa

Sapporo Medical University, Japan

Session I-A Future of Islet Transplantation
Chair
Raja Kandaswamy

Raja Kandaswamy

University of Minnesota, USA

Session I-B Worldwide Activity in Pancreas Transplantation
Chair
Takashi Kenmochi

Takashi Kenmochi

Fujita Health University, Japan

Session I-B History and Current Status of Organ Transplantation in Japan
Speaker
Byung Hyun Choi

Byung Hyun Choi

Pusan National University, Korea

Session I-B Pancreas Transplantation in Korea
Chair
Yi-Ming Shyr

Yi-Ming Shyr

Taipei Veterans General Hospital, Taiwan

Session I-B Pancreas Transplantation in Taiwan
Speaker
Yoshito Tomimaru

Yoshito Tomimaru

The University of Osaka, Japan

Session I-B Outcome of Pancreas Transplantation in Japan: Registry Report
Speaker
Taihei Ito

Taihei Ito

Fujita Health University, Japan

Session I-B Attempts to Expand the Indication Criteria for Pancreas Transplantation in Japan
Speaker
Sung-Min Park

Sung-Min Park

POSTECH, Korea

Session II-A Artificial Pancreas
Speaker
Se Hee Min

Se Hee Min

University of Ulsan, Korea

Session II-A Adjunctive Therapy in Type 1 Diabetes
Speaker
Joonyub Lee

Joonyub Lee

The Catholic University of Korea, Korea

Session II-A Application of Digital Twin Technology to the Treatment of Diabetes
Speaker
Naohiro Aida

Naohiro Aida

Fujita Health University, Japan

Session II-B Clinical Experience with Preformed and De Novo Donor-Specific Antibodies in Pancreas Transplant
Speaker
Shin-E Wang

Shin-E Wang

Taipei Veterans General Hospital, Taiwan

Session II-B Pancreas Re-Transplant at Taipei Veterans General Hospital
Chair
Matthew Cooper

Matthew Cooper

Medical College of Wisconsin, USA

Session II-B Current Challenges and Surgical Strategies in Pancreas Transplantation
Speaker
Shih-Chin Chen

Shih-Chin Chen

Taipei Veterans General Hospital, Taiwan

Session II-B Long-Term Follow-Up after Simultaneous Pancreas and Kidney Composite Graft Transplantation
Speaker
Keizo Kaku

Keizo Kaku

Kyushu University, Japan

Session II-B Transplant Potential of Non-Utilized Pancreas Grafts in Japan
Speaker
Heung Kyu Ko

Heung Kyu Ko

University of Ulsan, Korea

Session II-B Imaging and Intervention Care after Pancreas Transplantation
Speaker
Kihyun Lee

Kihyun Lee

Ewha Womans University, Korea

Session III-A Development of Gene and Cell Therapy using Pluripotent Stem Cells for Pancreatic Diseases
Speaker
Jong Cheol Jeong

Jong Cheol Jeong

Seoul National University, Korea

Session III-A Clinical Translation of Islet Xenotransplantation: Overcoming Immunologic Barriers
Speaker
Ik Jin Yun

Ik Jin Yun

Konkuk University, Korea

Session III-A The Necessity of Xeno-Islet Transplantation: Do We Really Need It?
Speaker
Christian Toso

Christian Toso

University of Geneva, Switzerland

Session IV-A Clinical Islet Transplantation
Chair
Tatsuya Kin

Tatsuya Kin

University of Alberta, Canada

Session IV-A Machine Perfusion of the Pancreas Prior to Islet Isolation: Two Decades of Lessons from the Edmonton Experience
Speaker
Masayuki Shimoda

Masayuki Shimoda

Japan Institute for Health Security, Japan

Session IV-A Islet Autotransplantation
Speaker
Ayana Esaki

Ayana Esaki

Fukuoka University, Japan

Session IV-A Coordination in Islet Transplantation
Speaker
Yumi Akashi

Yumi Akashi

Fujita Health University, Japan

Session IV-A Islet Registry Outcome in Japan